| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.13B | 13.62B | 10.33B | 9.29B | 9.09B | 7.77B |
| Gross Profit | 10.59B | 10.18B | 7.56B | 6.98B | 7.02B | 5.99B |
| EBITDA | 3.31B | 3.26B | 2.30B | 2.44B | 2.22B | 2.19B |
| Net Income | 2.05B | 2.02B | 1.40B | 1.51B | 1.39B | 1.33B |
Balance Sheet | ||||||
| Total Assets | 16.27B | 16.89B | 13.95B | 12.44B | 10.50B | 9.48B |
| Cash, Cash Equivalents and Short-Term Investments | 11.28B | 11.57B | 9.71B | 8.77B | 7.10B | 6.09B |
| Total Debt | 68.38M | 78.35M | 49.98M | 66.69M | 42.25M | 63.62M |
| Total Liabilities | 2.49B | 3.19B | 2.26B | 2.15B | 1.72B | 2.00B |
| Stockholders Equity | 13.78B | 13.71B | 11.69B | 10.29B | 8.78B | 7.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.99B | 1.18B | 1.61B | 1.07B | 1.64B |
| Operating Cash Flow | 0.00 | 1.99B | 1.25B | 1.62B | 1.07B | 1.64B |
| Investing Cash Flow | 0.00 | -162.73M | -286.51M | 25.85M | -37.86M | -74.93M |
| Financing Cash Flow | 0.00 | 28.22M | -25.96M | 24.44M | -21.61M | -21.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥34.15B | 18.51 | ― | 0.83% | 31.91% | 27.35% | |
63 Neutral | ¥45.52B | 58.36 | ― | ― | 22.37% | 655.34% | |
62 Neutral | ¥13.37B | 15.07 | 4.78% | ― | -10.17% | -19.44% | |
61 Neutral | ¥18.54B | 26.23 | ― | ― | 28.90% | 29.06% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
58 Neutral | ¥3.27B | 11.33 | ― | ― | 7.20% | 47.54% | |
40 Underperform | ¥2.14B | 83.90 | ― | ― | 4.36% | ― |